Author

R. C. Ungaro

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Approach:benchmark study· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1

Frequent Co-Authors

F. Petralia· 2 shared J.-F. Colombel· 2 shared S. Mehandru· 2 shared A. Bourreille· 1 shared A. D. Polydorides· 1 shared A. Dunn· 1 shared A. E. Livanos· 1 shared A. Fantou· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

F. Petralia

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Myeloid cell influx into the colonic epithelium is associated with disease severity and non-response to anti-Tumor Necrosis Factor Therapy in patients with Ulcerative Colitis.

D. Jha, Z. Al-Taie, A. Krek, S. T. Eshghi, A. Fantou, T. Laurent, M. Tankelevich, X. Cao, H. Meringer, A. Livanos, M. Tokuyama, F. Cossarini, A. Bourreille, R. Josien, R. Hou, , S. Mehandru

The paper identifies myeloid cell influx and epithelial cell perturbations in ulcerative colitis, linking them to disease severity and anti-TNF therapy non-response.

bioRxiv · Jun 2, 2023 · PreprintImmunology

Anti-integrin αvβ6 autoantibodies are a novel predictive biomarker in ulcerative colitis

A. E. Livanos, A. Dunn, J. Fischer, R. C. Ungaro, W. Turpin, S.-H. Lee, S. Rui, D. M. Del Valle, J. J. Julia, G. Martinez-Delgado, M. S. Riddle, J. A. Murray, R. M. Laird, J. Torres, M. Agrawal, , S. Mehandru

This study identifies anti-integrin αvβ6 autoantibodies as a predictive biomarker for ulcerative colitis, showing they precede diagnosis by up to 10 years and correlate with adverse outcomes.

bioRxiv · Nov 21, 2022 · PreprintImmunology